Skip to main content

Epoetin Alfa Injection Shortage

Last Updated: April 28, 2025
Status: Current

Products Affected - Description
    • Retacrit solution for injection, Pfizer, 10,000 unit/mL, 1 mL single dose vial, 10 count, NDC 00069-1308-10
    • Retacrit solution for injection, Pfizer, 2,000 unit/mL, 1 mL single dose vial, 10 count, NDC 00069-1305-10
    • Retacrit solution for injection, Pfizer, 20,000 unit/2 mL, 1 mL multiple dose vial, 10 count, NDC 00069-1318-10
    • Retacrit solution for injection, Pfizer, 20,000 unit/mL, 1 mL multiple dose vial, 10 count, NDC 00069-1311-10
    • Retacrit solution for injection, Pfizer, 3,000 unit/mL, 1 mL single dose vial, 10 count, NDC 00069-1306-10
    • Retacrit solution for injection, Pfizer, 4,000 unit/mL, 1 mL single dose vial, 10 count, NDC 00069-1307-10
    • Retacrit solution for injection, Pfizer, 40,000 unit/mL, 1 mL single dose vial, 4 count, NDC 00069-1309-04
Reason for the Shortage
    • Amgen has Epogen available.
    • Janssen has Procrit available.
    • Pfizer states the reason for the shortage is manufacturing delay.
Available Products
    • Epogen solution for injection, Amgen, 10,000 unit/mL, 1 mL single dose vial, 10 count, NDC 55513-0144-10
    • Epogen solution for injection, Amgen, 2,000 unit/mL, 1 mL single dose vial, 10 count, NDC 55513-0126-10
    • Epogen solution for injection, Amgen, 20,000 unit/2 mL, 2 mL multiple dose vial, 10 count, NDC 55513-0283-10
    • Epogen solution for injection, Amgen, 20,000 unit/mL, 1 mL multiple dose vial, 10 count, NDC 55513-0478-10
    • Epogen solution for injection, Amgen, 3,000 unit/mL, 1 mL single dose vial, 10 count, NDC 55513-0267-10
    • Epogen solution for injection, Amgen, 4,000 unit/mL, 1 mL single dose vial, 10 count, NDC 55513-0148-10
    • Procrit solution for injection, Janssen, 10,000 unit/mL, 1 mL single dose vial, 6 count, NDC 59676-0310-01
    • Procrit solution for injection, Janssen, 10,000 unit/mL, 1 mL single dose vial, 25 count, NDC 59676-0310-02
    • Procrit solution for injection, Janssen, 2,000 unit/mL, 1 mL single dose vial, 6 count, NDC 59676-0302-01
    • Procrit solution for injection, Janssen, 20,000 unit/2 mL, 2 mL multiple dose vial, 4 count, NDC 59676-0312-04
    • Procrit solution for injection, Janssen, 20,000 unit/mL, 1 mL multiple dose vial, 4 count, NDC 59676-0320-04
    • Procrit solution for injection, Janssen, 3,000 unit/mL, 1 mL single dose vial, 6 count, NDC 59676-0303-01
    • Procrit solution for injection, Janssen, 4,000 unit/mL, 1 mL single dose vial, 6 count, NDC 59676-0304-01
    • Procrit solution for injection, Janssen, 40,000 unit/mL, 1 mL single dose vial, 4 count, NDC 59676-0340-01

Estimated Resupply Dates

    • Pfizer has Retacrit 10,000 units/mL 1 mL vials, 20,000 units/mL 1 mL vials and 20,000 units/2 mL 1 mL vials on back order and the company estimates a release date of May 2025. The 2,000 units/mL 1 mL vials, 3,000 units/mL 1 mL vials, 4,000 units/mL 1 mL vials, and 40,000 units/mL 1 mL vials are available in limited supply with weekly releases.

Updated

Updated April 28, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 27, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer